Press Releases

Date

Title

View

20 May 20

4basebio AG: Simple and rapid SARS-CoV-2 diagnostic test project with 4basebio’s contribution receives funding from ‘la Caixa’ Banking Foundation

View View

14 May 20

4basebio AG: 4basebio AG reports first quarter 2020 financial results

View View

24 Apr 20

4basebio AG: 4basebio AG Reports positive Financial Results for Fiscal Year 2019 – Financial Guidance Met

View View

22 Apr 20

4basebio AG: 4basebio provides Phi29 DNA polymerase variants and expertise to develop improved detection system for SARS-CoV-2 infection

View View

21 Feb 20

4basebio AG announces allotment ratio and final number of shares for the share buy back

View View

21 Feb 20

4basebio AG: 4basebio AG announces allotment ratio and final number of shares for the share buy back

View View

18 Feb 20

Notification of the allotment ratio for the share buy back

View View

14 Feb 20

4basebio AG: 4basebio AG announces results of the public share buyback offerand final purchase price for the share buy back (news with additional features)

View View

10 Feb 20

4basebio AG: 4basebio AG decides to increase the public share buyback offer volume from 2,056,452 to 5,230,726 shares (news with additional features)

View View

21 Jan 20

4basebio AG: 4basebio AG decides to buy back 2 million treasury shares (news with additional features)

View View

21 Jan 20

4basebio AG: Expedeon AG completes change of name to 4basebio AG and of ticker symbol to 4BSB (news with additional features)

View View

02 Jan 20

Expedeon AG: Expedeon AG and Abcam plc close EUR 120 million transaction (news with additional features)

View View